Mangoceuticals, Inc. (MGRX) Q4 2025 Annual Earnings

Screener

Reported April 1, 2026 · Before market open

Revenue$94.4K

EPS$0.13

Next report

Date not yet announced

Versus estimates

Revenue

Q2 2026$68.8K Q1 2026$67.9K

Q4 2025$94.4K

Q3 2025$84.2K Q2 2025$168.1K Q1 2025$109.3K

Diluted EPS

Q2 2026-$0.09 Q1 2026-$0.22

Q4 2025$0.13

Q3 2025-$0.69 Q2 2025-$0.57 Q1 2025-$1.29

FAQ

When did Mangoceuticals, Inc. report Q4 2025 earnings?: Mangoceuticals, Inc. (MGRX) reported Q4 2025 earnings on April 1, 2026 before market open.
What were Mangoceuticals, Inc.'s Q4 2025 revenue and EPS?: Mangoceuticals, Inc. reported revenue of $94.4K and eps of $0.13 for Q4 2025.
How did Mangoceuticals, Inc.'s Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 10.3% from $105.2K a year earlier.
Where can I find Mangoceuticals, Inc.'s Q4 2025 SEC filings?: You can read the 10-K periodic report (0001493152-26-014478) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Mangoceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk